Nonendoscopic transnasal placement of a wireless capsule for esophageal pH monitoring: feasibility, safety, and efficacy of a manometry-guided procedure

Background and study aims: The aim of the study was to evaluate the safety, feasibility, and efficacy of transnasal placement of the Medtronic Bravo capsule for wireless esophageal pH monitoring.
Patients and methods: Forty patients with symptomatic gastroesophageal reflux disease were prospectively evaluated. All patients underwent upper gastrointestinal endoscopy and esophageal manometry. The Bravo capsule was then introduced transnasally and released 5 cm above the upper margin of the lower esophageal sphincter. Serial radiographs were performed weekly until capsule release.
Results: Of the 40 patients who were evaluated, 38 (95 %) were eligible to undergo the procedure. Transnasal placement proved impossible in one patient (2.5 %). Overall, a total of 39 procedures were performed in 38 patients (the procedure was repeated in one patient because of accidental intragastric fixation). Esophageal placement was successful in 36/39 procedures (92.3 %). The mean duration of the procedure was 10 minutes (range 5 - 16 minutes). Adverse events were noted in five of the 39 procedures (12.8 %), mild epistaxis in two patients (5.1 %) and pharyngeal irritation in three patients (7.7 %). After the procedure, a slight “foreign body” sensation was reported by 20 of the 36 patients (55.5 %) who had undergone successful esophageal placement; two patients (5.5 %) experienced severe retrosternal pain necessitating endoscopic removal of the capsule. At the end of the study, 34 of the 38 patients (89.5 %) stated that they would be willing to undergo the test again if necessary.
Conclusions: Transnasal placement of the Bravo pH capsule is safe, well tolerated, does not require sedation, and avoids endoscopy and its complications.

References

• 1 Spencer J. Prolonged pH recording in the study of gastroesophageal reflux.  Br J Surg. 1969;  56 912-914
• 2 Johnson L F, DeMeester T R. Twenty-four-hour pH monitoring of the distal esophagus.  Am J Gastroenterol. 1974;  62 325-332
• 3 Richter J E, Castell D O. Gastroesophageal reflux: pathogenesis, diagnosis, and therapy.  Ann Intern Med. 1982;  97 93-103
• 4 Decktor D L, Krawet S H, Rodriguez S L. et al . Dual site ambulatory pH monitoring: a probe across the lower esophageal sphincter does not induce gastroesophageal reflux.  Am J Gastroenterol. 1996;  91 1162-1166
• 5 Fass R, Hell R, Sampliner R E. et al . Effect of ambulatory 24-hour esophageal pH monitoring on reflux-provoking activities.  Dig Dis Sci. 1999;  55 2263-2269
• 6 Wiener G J, Morgan T M, Copper J B. et al . Ambulatory 24-hour esophageal pH monitoring. Reproducibility and variability of pH parameters.  Dig Dis Sci. 1988;  33 1127-1133
• 7 Food and Drug Administration 510K approval letter to Endonetics, Inc. September 29, 2000, available at: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.CFM?10=1640
• 8 Pandolfino J E, Richter J E, Ours T. et al . Ambulatory esophageal pH monitoring using a wireless system.  Am J Gastroenterol. 2003;  98 740-749
• 9 Ward E M, DeVault K R, Bouras E P. et al . Successful oesophageal pH monitoring with a catheter-free system.  Aliment Pharmacol Ther. 2004;  19 449-454
• 10 Tu C H, Lee Y C, Wang H P. et al . Ambulatory esophageal pH monitoring by using a wireless system: a pilot study in Taiwan.  Hepatogastroenterology. 2004;  51 1586-1589
• 11 Kahrilas P J, Clouse R E, Hogan W J. American Gastroenterological Association technical review on the clinical use of esophageal manometry.  Gastroenterology. 1994;  107 1865-1884
• 12 Kahrilas P J, Quigley E MM. Clinical esophageal pH recording: a technical review for practice guideline development.  Gastroenterology. 1996;  110 1982-1996
• 13 Passaretti S, Zaninotto G, Di Martino N. et al . Standards for esophageal manometry: a position statement from the Gruppo Italiano di Studio della Motilità Apparato Digerente (GISMAD).  Dig Liver Dis. 2000;  32 46-55
• 14 Branicki F J, Evans D F, Ogilvie A L. et al . Ambulatory monitoring of oesophageal pH in reflux oesophagitis using a portable radiotelemetry system.  Gut. 1982;  23 992-998
• 15 Streets C G, DeMeester T R, Peters J H. et al . Clinical evaluation of the BRAVO probe - a catheter-free ambulatory system [abstract].  Gastroenterology. 2001;  120 A35
• 16 Belafsky P C, Allen K, Castro-del Rosario L, Roseman D. Wireless pH testing as an adjunct to unsedated transnasal esophagoscopy: the safety and efficacy of transnasal telemetry capsule placement.  Otolaryngol Head Neck Surg. 2004;  131 26-28
• 17 Marchese M, Spera G, Spada C. et al . Safety and feasibility of transnasal placement of wireless pH-monitoring capsule [abstract].  Gut. 2004;  53 (Suppl VI) A109
• 18 Pandolfino J E. Bravo capsule pH monitoring.  Am J Gastroenterol. 2005;  100 8-10
• 19 Dumortier J, Napoleon B, Hedelius F. et al . Unsedated transnasal EGD in daily practice: results with 1100 consecutive patients.  Gastrointest Endosc. 2003;  57 198-204
• 20 DeVault K R, Castell D O. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. The Practice Parameters Committee of American College of Gastroenterology.  Am J Gastroenterol. 1999;  94 1434-1442
• 21 Kahrilas P J, Lin S, Chen J. et al . The effect of hiatus hernia on gastro-oesophageal junction pressure.  Gut. 1999;  44 476-482
• 22 Anggiansah A, Sumboonnanonda K, Wang J. et al . Significantly reduced acid detection at 10 centimeters compared to 5 centimeters above lower esophageal sphincter in patients with acid reflux.  Am J Gastroenterol. 1993;  88 842-846
• 23 Walker S J, Holt S, Sanderson C J. et al . Does the position of the probe affect the results of oesophageal pH monitoring?.  [Abstract] Gut. 1991;  32 A1242
• 24 Singh P, Adamopoulos A, Taylor R. et al . Results of simultaneous two-level oesophageal pH monitoring in patients with gastroesophageal reflux disease and controls.  [Abstract] Gut. 1991;  32 A1214
• 25 Ruiz-de Leon A, Sevilla-Mantilla C, Perez-de la Serna J. et al . Simultaneous two-level esophageal 24-hour pH monitoring in patients with mild and severe esophagitis: does probe position influence results of esophageal monitoring.  Dig Dis Sci. 1995;  40 1423-1427
• 26 Klauser A G, Schindlbeck N E, Muller-Lissner S A. Esophageal 24-h pH monitoring: is prior manometry necessary for correct positioning of the electrode?.  Am J Gastroenterol. 1992;  87 967-970
• 27 Bell G D, McCloy R F, Charlton J E. et al . Recommendations for standards of sedation and patient monitoring during gastrointestinal endoscopy.  Gut. 1991;  32 823-827
• 28 Holm C, Christensen M, Rasmussen V. et al . Hypoxemia and myocardial ischemia during colonoscopy.  Scand J Gastroenterol. 1998;  33 769-772
• 29 Martin L. Predictive factors of oxygen desaturation during upper gastrointestinal endoscopy in nonsedated patients.  Gastrointest Endosc. 1998;  48 143-147
• 30 Müller-Linsner S A, Blum A L. Fundic pressure rise lowers lower esophageal sphincter pressure in man.  Hepatogastroenterology. 1992;  29 151-152
• 31 Hananoki M, Haruma K, Tsuga K. et al . Evaluation of lower oesophageal sphincter pressure using endoscopic manometric sleeve assembly.  J Gastroenterol Hepatol. 2000;  15 121-126
• 32 Bothwell M, Phillips J, Bauer S. Upper esophageal pH monitoring of children with the Bravo pH capsule.  Laryngoscope. 2004;  114 786-788